Influence of State Telehealth Regulations on Treatment for Substance Use Disorders During the COVID-19 Crisis - Top-Institutions - MDSpire

Influence of State Telehealth Regulations on Treatment for Substance Use Disorders During the COVID-19 Crisis

  • By

  • Matthew D. Eisenberg

  • Kayla N. Tormohlen

  • Alexander D. McCourt

  • Jiani Yu

  • Raghavee Neupane

  • Yimin Ge

  • Elizabeth A. Stuart

  • Michael Fingerhood

  • Nicholas J. Seewald

  • Emma Elizabeth McGinty

  • April 17, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Addiction Medicine
    • Health Policy
    • Telehealth Research

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Addiction Psychiatry
    • Telemedicine
    • Health Services Research

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Addiction Medicine
    • Digital Health
    • Health Policy

  • #4

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, NY

    Key Differentiators

    • Addiction Psychiatry
    • Telehealth
    • Health Policy Research

  • #5

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Addiction Medicine
    • Telehealth Implementation
    • Health Services Research

Original Source(s)

Influence of State Telehealth Regulations on Treatment for Substance Use Disorders During the COVID-19 Crisis

  • by Matthew D. Eisenberg, Kayla N. Tormohlen, Alexander D. McCourt, Jiani Yu, Raghavee Neupane, Yimin Ge, Elizabeth A. Stuart, Michael Fingerhood, Nicholas J. Seewald, Emma Elizabeth McGinty

  • April 17, 2026

Related Content

Challenges and Enablers in Platform Trial Methodologies

Estimating Effectiveness of Influenza and COVID-19 Vaccines: The “Test-Negative” Design

Error in Conclusions

  • May 1, 2026